Annual report pursuant to Section 13 and 15(d)

Impairment, Restructuring and Other Costs

v3.24.4
Impairment, Restructuring and Other Costs
12 Months Ended
Dec. 31, 2024
Restructuring and Related Activities [Abstract]  
Impairment, Restructuring and Other Costs Impairment, Restructuring and Other Costs
During the year ended December 31, 2024, impairment, restructuring and other costs were $3,453 which consisted of impairment charges of $3,355 primarily related to impairments of goodwill and equity method investments, costs associated with the Transactions of $71, and a charge of $27 associated with severance and other restructuring costs. Refer to Notes 8 and 12 for more information on the goodwill and equity method investment impairment charges, respectively.
During the year ended December 31, 2023, impairment, restructuring and other costs were $92 which consisted of a charge of $34 primarily related to severance and other related costs, costs associated with the Transactions of $26, impairments primarily related to terminated software projects of $15, vacated office space impairments of $12, accrued expenses of $3 for which we will not recognize any future economic benefit, and a cost-method investment impairment of $2. The restructuring and related impairment charges were recorded to Impairment, restructuring and other costs in our audited consolidated statements of operations.
During the year ended December 31, 2022, impairment, restructuring and other costs were $68 which consisted of an impairment of $43 associated with terminated software projects, $16 related to certain vacated office spaces, $5 in connection
with furniture and equipment located at the impaired office spaces, and $6 related to personnel severance as well as acquisition related costs of $2, partially offset by $4 from a gain on sale of real estate. The restructuring and related impairment charges were recorded to Impairment, restructuring and other costs in our audited consolidated statements of operations.